Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06369467
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2024-04-11
Brief Title:
Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E IgE-Mediated Food Allergy
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Organization Data
Organization:
Regeneron Pharmaceuticals
Class:
INDUSTRY
Study ID:
R5458-668-ALG-2219
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Regeneron Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None